Price
No data yet.
Social Signal Score
Analyst Ratings
15 analystsRevenue
$54.65M+100.23%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Clay Ritchey
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 682
- Beta
- 1.36
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- -3.10
Financials
Revenue
$54.65M+100.2%Net Income
$-3.89MEBITDA
$5.54M-52.9%Free Cash Flow
$9.04M+40.6%EPS (diluted)
$-0.04Shares Outstanding (diluted)
106.77M-9.8%Operating Expenses
$38.18MCash & Debt
$190.30MReturn of Capital
$251.0KRevenue by Segment (annual)
$241.52MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $241.52M | $-138.93M | $-1.30 |
| 2024 | $252.20M | $-413.12M | $-3.54 |
| 2023 | $251.41M | $-202.39M | $-1.79 |
| 2022 | $222.65M | $-7.22M | $-0.07 |
| 2021 | $166.15M | $-51.91M | $-0.19 |
| 2020 | $118.32M | $-52.60M | $-0.53 |
| 2019 | $85.50M | $-36.40M | $-0.24 |
Valuation
DHhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
95-5.00%Social Signal Score
Mentions (7)
- Newsglobenewswire.com·6d ago·Neutral
Healthcare Leaders Turn Months-Long Analyses Into Minutes With AI-Powered Growth Intelligence Platform Definitive Healthcare shares early-adopter findings for new AI-powered growth intelligence platform used to power critical healthcare decisions and commercial progress Definitive Healthcare shares early-adopter findings for new AI-powered growth intelligence platform used to power critical healthcare decisions and commercial progress
View source ↗ - Newsglobenewswire.com·18d ago·Negative
Definitive Healthcare announces executive appointments to bolster AI-powered initiatives across the company Healthcare Data and Analytics Organization Hires Head of AI and Promotes New Chief Product Officer Healthcare Data and Analytics Organization Hires Head of AI and Promotes New Chief Product Officer
View source ↗ - Newsglobenewswire.com·52d ago·Positive
Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing Alongside other industry leaders, Definitive Healthcare demonstrates commitment to the highest standard of health data safety Alongside other industry leaders, Definitive Healthcare demonstrates commitment to the highest standard of health data safety
View source ↗ - Newsglobenewswire.com·81d ago·Neutral
Definitive Healthcare Appoints Clay Ritchey as CEO FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective September 8, 2026.
View source ↗ - Newsseekingalpha.com·104d ago·Positive
Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·104d ago·Positive
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.07 per share a year ago.
View source ↗ - Newsmarketbeat.com·104d ago·Neutral
Definitive Healthcare Q2 Earnings Call Highlights Definitive Healthcare NASDAQ: DH reported second-quarter fiscal 2026 revenue and profitability that met or exceeded its guidance ranges, while management pointed to improving retention trends and continued investments in artificial intelligence products as key components of its plan to return to growth.
View source ↗
Earnings
Thu, Feb 25(in 3 months)
Consensus estimate $0.04 per share
Typical surprise +40.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Nov 5$0.06 vs $0.04beat
- Mon, Aug 10$0.05 vs $0.04beat
- Thu, May 7$0.06 vs $0.03beat
- Thu, Feb 26$0.06 vs $0.06beat
- Thu, Nov 6$0.07 vs $0.06beat
- Thu, Aug 7$0.07 vs $0.05beat
Estimates and results for DH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by DH officers and directors.
- Bought
- —
- Sold
- $212k
0 trades
1 trade
- Moschella Williamsold
99 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in DH.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
